SCHEMBL4982249

SCHEMBL4982249

CC(Oc1nc(Cl)nc(N2CCC(C)(O)CC2)c1F)c1ncc(F)cn1.Cc1cc(Nc2nc(OC(C)c3ncc(F)cn3)c(F)c(N3CCC(C)(O)CC3)n2)n[nH]1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 18/20 0.71
JAK3 P52333 18/20 0.71
AURKA O14965 2/20 0.41
PLK4 O00444 1/20 0.41
STK10 O94804 1/20 0.41
PAK4 O96013 1/20 0.41
NTRK1 P04629 1/20 0.41
RET P07949 1/20 0.41
FGFR1 P11362 1/20 0.41
FER P16591 1/20 0.41
CSNK2A2 P19784 1/20 0.41
JAK1 P23458 1/20 0.41
TYK2 P29597 1/20 0.41
FLT3 P36888 1/20 0.41
STAT3 P40763 1/20 0.41
STAT5A P42229 1/20 0.41
CDK3 Q00526 1/20 0.41
PTK2 Q05397 1/20 0.41
TNK2 Q07912 1/20 0.41
STK4 Q13043 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4982598 0.95 JAK2 (0.78) JAK2JAK3
SCHEMBL4977038 0.95 JAK2 (0.78) JAK2JAK3
SCHEMBL4983023 0.85 JAK2 (0.69) JAK2JAK3AURKAPLK4STK10
SCHEMBL4981256 0.83 JAK2 (1.00) JAK2JAK3
SCHEMBL4985706 0.83 JAK2 (0.58) JAK2JAK3AURKAPAK4AURKB
SCHEMBL4978192 0.81 JAK2 (0.78) JAK2JAK3
SCHEMBL4978181 0.81 JAK2 (0.78) JAK2JAK3
SCHEMBL4980582 0.81 JAK2 (0.77) JAK2JAK3AURKAPLK4STK10
SCHEMBL4980576 0.81 JAK2 (0.77) JAK2JAK3AURKAPLK4STK10
SCHEMBL4978435 0.80 JAK2 (0.75) JAK2JAK3NTRK1AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008132502-A1 PYRAZOLYL-AMINO-SUBSTITUTED PYRIMIDINES AND THEIR USE FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2008-11-06 WO disclosed